Upsurge of Enterovirus D68 Infection in the Lower Hudson Valley, New York, 2016 by Farooq, Taliya et al.
Touro Scholar 
NYMC Faculty Posters Faculty 
3-2-2017 
Upsurge of Enterovirus D68 Infection in the Lower Hudson Valley, 
New York, 2016 
Taliya Farooq 
New York Medical College, taliya_farooq@nymc.edu 
Esther C. Yoon 
New York Medical College, esther_yoon@nymc.edu 
Jian Zhuge 
New York Medical College 
Changhong Yin 
New York Medical College, changhong_yin@nymc.edu 
Wei-Hua Huang 
New York Medical College, weihua_huang@nymc.edu 
See next page for additional authors 
Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_posters 
 Part of the Virus Diseases Commons 
Recommended Citation 
Farooq, T., Yoon, E. C., Zhuge, J., Yin, C., Huang, W., Nolan, S. M., Fallon, J. T., & Wang, G. (2017). Upsurge 
of Enterovirus D68 Infection in the Lower Hudson Valley, New York, 2016. Retrieved from 
https://touroscholar.touro.edu/nymc_fac_posters/25 
This Poster is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for 
inclusion in NYMC Faculty Posters by an authorized administrator of Touro Scholar.For more information, please 
contact touro.scholar@touro.edu. 
Authors 
Taliya Farooq, Esther C. Yoon, Jian Zhuge, Changhong Yin, Wei-Hua Huang, Sheila M. Nolan, John T. 
Fallon, and Guiqing Wang 
This poster is available at Touro Scholar: https://touroscholar.touro.edu/nymc_fac_posters/25 
Upsurge of Enterovirus D68 Infection in the Lower Hudson Valley, New York, 2016 
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John T. Fallon, III, MD, PhD1 and Guiqing Wang PhD1 
 
1 New  York Medical College at Westchester Medical Center, Pathology, Valhalla, New York and  
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In 2014, a nationwide outbreak of severe respiratory illness associated 
with Enterovirus D68 was reported in the US. There were no EV-D68 
cases during the 2015 enterovirus season per CDC's National 
Enterovirus Surveillance System (NESS).  
Upsurge of EV-D68 infection were reported in Europe in 2016 [1-2], 
but there were only sporadically cases in the US per CDC [3].  
The aims of this study are to determine if EV-D68 was circulating in 
patients in the Lower Hudson Valley, New York in 2016, and if so, 
whether there were any significant variations in the virus genome or 
the severity of clinical diseases.  
 
 
 MATERILAS & METHODS 
BACKGROUND 
USCAP 2017, Poster Number: 1563  
Study site. Lower Hudson Valley, New York, USA. 
 
Detection of RhV/EV by FilmArray RP assay, 2014-2016. A total of 
11,715 NP specimens were analyzed. The overall positivity was 49.4% 
by RP, with ~25% positive for RhV/EV (Fig.1 & Table 1). 
EV-D68 detection, 2014-2016. EV-D68 was confirmed in 94 cases in 
2014 and none in 2015 (Fig. 2).   
EV-D68 was detected in 1/108 (0.9%) RhV/EV-positive NP specimens 
from January through May 2016, and 159/442 (36.0%) NP specimens 
from June through October 2016 by rRT-PCR (Table 2). 
EV-D68 genomes and phylogenetic analysis of 2016 strains. 
Complete EV-D68 genomes from 22 patient specimens in 2016 were 
obtained. A new subclade B3 strain, which was ~4.5% divergent in 
nucleotides from the B1 causing outbreak in 2014, was identified 
(Table 3, Fig. 3 & Fig. 4). 
RESULTS 
CONCLUSIONS 
A new EV-D68 subclade B3 circulating in the US caused an outbreak 
in the Lower Hudson Valley, New York with 160 laboratory-confirmed 
cases in 2016.  
Multiple mutations in the viral genomes of B3 strains and variations in 
the spectrum and severity of clinical diseases were observed. 
Enhance surveillance and more accurate lab diagnostic testing for 
detection of EV-D68 in clinical specimens are warranted.  












Jan-Dec 2014 3,762 1,769 47.0 917 24.4 
Jan-Dec 2015 4,310 2,131 49.4 1,034 24.0 
Jan-Oct 2016 3,643 1,882 51.7 985 27.0 
Total 11,715 5,782 49.4 2,936 25.1 
Table 1.  Number of nasopharyngeal specimens examined by 
FilmArray RP during the period from 2014 to 2016 






No. tested by 








Jan-May 416 108 (26.0)  107 1 0.9 
June 71 70 (98.6) 39 31 44.3 
July 86 86 (100) 60 26 30.2 
August 80 79 (98.8) 28 51 64.6 
September 96 96 (100) 58 38 39.6 
October 112 111 (99.1) 98 13 11.7 
Total  861 550 (63.9) 390 160 29.1 
Table 2.  Number of nasopharyngeal specimens examined by the 





Sequence identity range (%) 
Nucleotide, 
genome  
Nucleotide,   VP1 
Amino acid, 
polyprotein  
Amino acid,         
VP1 
B3 vs. A 90.7-91.0 87.8-88.9 98.1-98.2 95.9-97.1 
B3 vs. B1 95.5-95.8 95.4-96.5 99.0-99.3 98.6-99.4 
B3 vs. B2 93.8-94.2 93.2-94.5 99.2-99.5 99.1-99.8 
B3 vs. C 92.0-92.4 90.8-92.2 98.8-99.1 96.6-97.8 
B3 vs. D 89.7-89.9 97.3-88.8 98.2-98.3 96.4-97.4 
B3 vs. Fermon 87.7-88.1 85.3-86.7 97.6-97.7 94.0-95.0 
Table 3. Nucleotide and amino acid sequence identity between subclade B3 and other subtypes of EV-
D68 strains 
Figure 1. Weekly distribution of RhV/EV-positive NP specimens 
by the FilmArray RP assay, 2014 through October 2016.    
Figure 2.  Enterovirus D68 detected by rRT-PCR in NP 
specimens collected from 2013 through October 2016. 
Figure 3. (A) Collapsed phylogenetic tree of enterovirus D68 based on nucleotide sequences of 341 complete or nearly complete 
genomes. Strains of EV-D70 and EV-D90 were used as outgroup; (B) An enlarged phylogenetic tree of EV-D68 subclade B3 strains (n 
= 50). Strains from China (CHN) and Taiwan (TW) were shown in red and pink, respectively, whereas strains from the US were shown 
in green. One strain representing each of other clades (A, C, D, B1, B2 and prototype) was included for comparison.  
 
Clinical samples. Nasopharyngeal (NP) 
specimens from patients with respiratory 
illness and/or neurologic symptoms.  
Respiratory multiplex PCR (RP) assay. NP 
specimens were examined for Rhinovirus/ 
Enterovirus (RhV/EV) and other respiratory 
pathogens using the FilmArray™ RP assay.  
 EV-D68 rRT-PCR and Next-Generation Sequencing. NP specimens 
positive for RhV/EV were analyzed with an EV-D68-specific rRT-PCR 
assay [4] and next-generation sequencing (NGS) on the Illumina 
MiSeq [5]. 
Phylogenetic analysis was performed using the BioNumerics v7.6. 
(Applied Maths, Belgium). 
Clinical characteristics of patients with EV-D68 in 2016. The 
median age of 160 patients was 3.2 years (3 wks to 91 years) and 
62.5% were male. 145 (90.6%) were pediatric patients. The common 
clinical presentations included fever (70.2%), cough (72.1%), 
wheezing (51%), and increased work of breathing (58.6%). Thirty-
one (29.8%) pediatric patients required intensive care unit admission 
in 2016, comparable to 23 of 80 (28.8%) patients in 2014. Acute 
flaccid myelitis (AFM) was confirmed in two pediatric patients with 5 
and 21 months of age, respectively. 
Identification of a new subclade B3 circulating in the US in 2016 (Figure 3) 
Figure 4. Amino acid (aa) polymorphisms of EV-D68 subclade B3 based on the entire polypeptide sequences 
of approximate 2,188 aa. Twenty-eight amino acid polymorphisms were identified in subclade B3 strains from 
the US in 2016, as compared to those of subclade B1 from US in 2014.   
* Contributed equally to this work. 
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